Risk of Venous Thromboembolism/Pulmonary Embolism with Intravenous Immunoglobulin Administration across Various Diseases: NIS Database Analysis 2016-2020

Authors

Aditya Sanjeevi, Rochester Regional HealthFollow
Aniket-Vijay Rao, Rochester Regional HealthFollow
Daniel Jose Idoate Domench, Rochester Regional HealthFollow
Purva Shah, Rochester Regional HealthFollow
Abdullah A. Orakzai, Rochester Regional HealthFollow
Samikchhya Keshary Bhandari, Maharajgunj Medical Campus, Tribhuvan University Institute of Medicine, Kathmandu, Nepal.
Himal Kharel, Rochester Regional HealthFollow

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Blood

Conference Name

American Society of Hematology (ASH) Annual Meeting

Conference Date

2024-12-07 - 2024-12-10

First Page

5587

DOI

10.1182/blood-2024-212349

Volume

144

Issue

Supplement 1

Publication Date

11-5-2024

Recommended Citation

Sanjeevi, A., Rao, A., Idoate Domench, D., Shah, P., Orakzai, A. A., Bhandari, S. K., & Kharel, H. (2024). Risk of Venous Thromboembolism/Pulmonary Embolism with Intravenous Immunoglobulin Administration across Various Diseases: NIS Database Analysis 2016-2020. Blood, 144 (Supplement 1), 5587. https://doi.org/10.1182/blood-2024-212349